Tech Company Financing Transactions

RefleXion Medical Funding Round

RefleXion Medical, operating out of Hayward, raised $52 million in funding from KCK Group, Johnson & Johnson Development Corporation and Pfizer Venture Investments.

Transaction Overview

Company Name
RefleXion Medical
Announced On
4/14/2016
Transaction Type
Venture Equity
Amount
$52,000,000
Round
Series B
Investors

KCK Group (Lead Investor) (Greg Garfield)

Johnson & Johnson Development Corporation

Pfizer Venture Investments (William Burkoth)

Sofinnova Ventures (Antoine Papiernik)

Venrock (Colin Cahill)

Proceeds Purpose
Proceeds from the Series B financing will be allocated towards expanding RefleXion's Engineering, Regulatory and Commercial organizations.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
25841 Industrial Blvd. 275
Hayward, CA 94545
USA
Phone
(650) 239-9070
Website
www.reflexion.com
Email Address
[email protected]
Overview
RefleXion Medical is developing the first biologically guided radiation therapy system for treating solid tumors throughout the body.
Profile
RefleXion Medical LinkedIn Company Profile
Social Media
RefleXion Medical Company Twitter Account
Company News
RefleXion Medical News
Facebook
RefleXion Medical on Facebook
YouTube
RefleXion Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Todd Powell
  Todd Powell LinkedIn Profile  Todd Powell Twitter Account  Todd Powell News  Todd Powell on Facebook
Chief Financial Officer
Martyn Webster
  Martyn Webster LinkedIn Profile  Martyn Webster Twitter Account  Martyn Webster News  Martyn Webster on Facebook
Chief Technical Officer
Sam Mazin
  Sam Mazin LinkedIn Profile  Sam Mazin Twitter Account  Sam Mazin News  Sam Mazin on Facebook
VP - Bus. Development
Thorsten Melcher
  Thorsten Melcher LinkedIn Profile  Thorsten Melcher Twitter Account  Thorsten Melcher News  Thorsten Melcher on Facebook
VP - Marketing
Judy Bartlett-Roberto
  Judy Bartlett-Roberto LinkedIn Profile  Judy Bartlett-Roberto Twitter Account  Judy Bartlett-Roberto News  Judy Bartlett-Roberto on Facebook
VP - Operations
Philip Aulson
  Philip Aulson LinkedIn Profile  Philip Aulson Twitter Account  Philip Aulson News  Philip Aulson on Facebook
VP - Operations
Philip Philip
  Philip Philip LinkedIn Profile  Philip Philip Twitter Account  Philip Philip News  Philip Philip on Facebook
VP - R & D
David Larkin
  David Larkin LinkedIn Profile  David Larkin Twitter Account  David Larkin News  David Larkin on Facebook
VP - Regulatory Affairs
Kathy O'Shaughnessy
  Kathy O'Shaughnessy LinkedIn Profile  Kathy O'Shaughnessy Twitter Account  Kathy O'Shaughnessy News  Kathy O'Shaughnessy on Facebook
VP - Regulatory Affairs
Shervin Shirvani
  Shervin Shirvani LinkedIn Profile  Shervin Shirvani Twitter Account  Shervin Shirvani News  Shervin Shirvani on Facebook
VP - Sales
Leonard Lyons
  Leonard Lyons LinkedIn Profile  Leonard Lyons Twitter Account  Leonard Lyons News  Leonard Lyons on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/14/2016: Kala Pharmaceuticals venture capital transaction
Next: 4/14/2016: PrideBites venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.